Tilley says negotiations still going on over pill bill, hopes for passage of meth and synthetic drug bills
03/26/2012 05:25 PM
The House and Senate still are trying to iron out differences between the two chambers’ approaches to better regulating prescription pills in a compromise that Senate Judiciary Chairman Tom Jensen, R-London, said he hopes to unveil Tuesday.
His House Democratic counterpart, Rep. John Tilley, D-Hopkinsville, said on Pure Politics Monday that the big difference is whether the prescription monitoring system known as KASPER will move to the attorney general’s office, as the House wants, or remain under control of the Health and Family Services Cabinet.
“We’re still negotiating that particular point right down to the wire,” he said at 2:30. “And there are far more similarities between the bills than there are differences.”
Tilley also gave his take on the future of the bill aimed at curbing methamphetamine production by capping the amount of cold medicine with pseudoephedrine that Kentuckians can get without a prescription. (5:00)
And he also answered questions about his bill to make illegal the mixing of whole classes of synthetic drugs (8:00).
Tilley said locking down agreements on that trio of issues can salvage what otherwise has been a difficult legislative session that got off to a slow start because of controversy over redistricting.
“The drug abuse problem — the scourge in Kentucky — is the worst problem we have, period, in my opinion,” he said (10:15). “If we can pass House Bill 4 or Senate Bill 2 or some combination of the two bills to address pill mills … we can address synthetic drugs and we can also look at addressing the meth problem … I think this will be a successful session if we can just address those three issues.”
Below the Fold
Sen. Paul, back in surgeon's gown, removes cataracts pro bono, reaffirms Trump endorsement in Louisville
Subscribe and get the latest political intelligence delivered to your inbox.